ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
METX ME Therapeutics Holding Inc
- 4.150
- 0.0000.00%
15min DelayMarket Closed Dec 12 12:45 ET
104.54MMarket Cap-83.00P/E (TTM)
0.000High0.000Low0Volume0.000Open4.150Pre Close0.00Turnover7.50052wk High0.00%Turnover Ratio25.19MShares0.75052wk Low-0.05EPS TTM45.83MFloat Cap7.500Historical HighLossP/E (Static)11.04MShs Float0.050Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM70.34P/B1Lot Size--Div YieldTTM
ME Therapeutics Holding Inc Key Stats
Quarterly+Annual
YOY
| (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q1)Dec 31, 2022 | (FY)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -117.00%-657.92K | -48.92%-150.26K | 2.58%-142.98K | -99.25K | -1,078.96%-265.43K | -123.46%-303.2K | -100.9K | -146.77K | -22.51K | -135.69K |
| Net income from continuing operations | 80.14%-1.29M | 89.41%-312.04K | 85.81%-495.99K | ---143.49K | -431.40%-343.11K | -4,372.64%-6.52M | ---2.95M | ---3.49M | ---64.57K | ---145.78K |
| Depreciation and amortization | -20.41%39 | -25.00%9 | -16.67%10 | --11 | --9 | -19.67%49 | --12 | --12 | ---- | --61 |
| Remuneration paid in stock | 17.45%690.89K | -31.20%170.87K | -10.11%305.5K | --6.92K | --207.6K | 4,198.90%588.22K | --248.35K | --339.87K | ---- | --13.68K |
| Other non cashItems | -99.85%8.58K | --0 | -99.96%1.25K | --2.93K | --4.4K | 51,625.44%5.59M | --2.58M | --2.99M | ---- | --10.8K |
| Change In working capital | -247.48%-62.8K | -165.85%-9.1K | 129.20%46.25K | --34.38K | -419.42%-134.33K | 394.77%42.58K | --13.82K | --20.18K | --42.05K | ---14.45K |
| -Change in receivables | -160.76%-9.37K | -239.08%-3.52K | -228.20%-5.05K | --22.98K | ---23.78K | 175.05%15.42K | ---1.04K | ---1.54K | ---- | ---20.55K |
| -Change in prepaid assets | 47.87%-7.87K | -41.89%-21.74K | -81.57%4.55K | --49.95K | ---40.63K | -583.97%-15.1K | ---15.32K | --24.7K | ---- | ---2.21K |
| -Change in payables and accrued expense | -207.80%-45.56K | -46.42%16.17K | 1,665.61%46.75K | ---38.56K | -266.26%-69.92K | 408.48%42.26K | --30.18K | ---2.99K | --42.05K | --8.31K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -117.00%-657.92K | -48.92%-150.26K | 2.58%-142.98K | ---99.25K | -1,078.96%-265.43K | -123.46%-303.2K | ---100.9K | ---146.77K | ---22.51K | ---135.69K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 757.44K | 0 | 0 | |||||
| Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | --757.44K | --0 | ---- | ---- | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | ---- | ---- | ---- | --757.44K | --0 | ---- | ---- | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,204.91%1.51M | -106.49%-7.5K | 450K | -17.48%115.53K | 115.53K | 0 | 125K | 140K | ||
| Net issuance payments of debt | ---40K | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | --140K |
| Net common stock issuance | 1,246.03%1.56M | --0 | ---- | ---- | ---- | --115.53K | ---- | ---- | --125K | --0 |
| Proceeds from stock option exercised by employees | ---7.5K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,204.91%1.51M | -106.49%-7.5K | --450K | ---- | ---- | -17.48%115.53K | --115.53K | --0 | --125K | --140K |
| Net cash flow | ||||||||||
| Beginning cash position | 736.35%647.15K | 161.57%1.65M | 6,066.33%1.35M | --381.72K | 62.64%647.15K | 5.91%77.38K | --632.52K | --21.85K | --397.91K | --73.06K |
| Current changes in cash | 49.11%849.58K | -1,178.77%-157.76K | -49.72%307.02K | --965.75K | -358.99%-265.43K | 13,104.36%569.77K | --14.62K | --610.67K | --102.49K | --4.32K |
| End cash Position | 131.28%1.5M | 131.28%1.5M | 161.57%1.65M | --1.35M | -23.72%381.72K | 736.35%647.15K | --647.15K | --632.52K | --500.4K | --77.38K |
| Free cash from | -117.00%-657.92K | -48.92%-150.26K | 2.58%-142.98K | ---99.25K | -1,078.96%-265.43K | -123.46%-303.2K | ---100.9K | ---146.77K | ---22.51K | ---135.69K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.